The reiteration of a Buy rating and the maintenance of a high price target by a reputable analyst firm like HC Wainwright & Co. can positively influence investor sentiment and potentially lead to an increase in stock price in the short term. The specific mention of Apellis Pharmaceuticals and the reaffirmation of a $92 price target underscore the firm's confidence in the company's prospects.